Sponsored by: GE Healthcare

Molecular Imaging: Page 42

FDG-PET helps forecast outcome in neuroendocrine tumors
By Wayne Forrest
FDG-PET/CT can be used to classify neuroendocrine tumor patients into different prognostic categories for peptide receptor radionuclide therapy, German researchers have found. The decision to perform FDG-PET/CT should be based on the grading, time course of the disease, speed of progression, total tumor mass, and other criteria, they say.
March 19, 2020
2019 12 13 19 51 1879 Carcinoid Neuroendocrine Tumor 400
PET tracks down causes of fever in children
By Tami Freeman, PhD
In children with fever of unknown origin, imaging studies are scarce and the usefulness of FDG-PET/CT remains uncertain. Now a Dutch team has examined a large group of children in an attempt to fill the knowledge void.
March 12, 2020
2020 03 12 18 48 4411 2020 03 13 Pet Fever 20200312182919
Eckert & Ziegler begins production of lutetium-177
By AuntMinnieEurope.com staff writers
Isotope technology developer Eckert & Ziegler said it has begun commercial production of carrier-free lutetium-177.
March 10, 2020
European groups sponsor hybrid imaging fellowship
By AuntMinnieEurope.com staff writers
The European School of Radiology (ESOR) and the European Society for Hybrid, Molecular and Translational Imaging (ESHIMT) are receiving applications for its hybrid imaging fellowship program.
March 8, 2020
2020 03 09 20 45 0805 Pet Ct Machine 400
Magnetized molecules monitor breast cancers
By Belle Dumé
A new technique that uses hyperpolarized carbon-13 MRI to monitor the metabolism of different types of breast cancer can identify how rapidly a tumor is growing, U.K. researchers report. The approach could help doctors prescribe the best course of treatment and follow how patients respond.
March 5, 2020
2020 03 05 00 04 5734 2020 03 06 Pyruvate Lactate 20200305000541
Curium acquires Zevacor Molecular
By AuntMinnieEurope.com staff writers
Nuclear medicine firm Curium Pharma has acquired radiopharmaceutical developer Zevacor Molecular in a deal aimed at strengthening its PET portfolio.
March 2, 2020
2019 12 19 00 53 5252 Hands Shaking Deal 400
Isotopia, Eckert & Ziegler partner
By AuntMinnieEurope.com staff writers
Isotopia Molecular Imaging has partnered with isotope technology firm Eckert & Ziegler for the development of its PSMA-11 kit for prostate cancer imaging.
February 16, 2020
2019 11 11 22 17 5854 Arrows Join Partner 400
PentixaPharm gets 15M euros for radiopharmaceutical trials
By AuntMinnieEurope.com staff writers
PentixaPharm has announced 15 million euros in funding to test a pair of radiopharmaceutical drugs to identify fast-progressing diseases, including cancer.
February 6, 2020
2019 07 04 00 21 3668 Euros Bills 400
AuntMinnieEurope.com Molecular Imaging Insider
By Wayne Forrest
February 3, 2020
FDG-PET displays its prowess in dementia detection
By Wayne Forrest
In a direct comparison, FDG-PET proved superior to MRI with arterial spin labeling for diagnosing and differentiating various forms of dementia; however, there remains a need for the latter modality, a new Belgian study has found.
February 3, 2020
2020 02 05 17 44 6057 Fdg Pet Asl Mr Alzheimers 400
Timing tests promise to improve PET performance
By Susan Curtis
Researchers at CERN, the European Organization for Nuclear Research, have placed new limits on the timing performance of systems for time-of-flight PET. Their aim is to enhance the quality of PET images, enabling doctors to reduce the dose of radioactive tracer they administer to patients.
January 30, 2020
2020 01 30 19 11 9897 Cern Switzerland 400
Viennese biomarker study casts light on breast cancer risk
By Brian Casey
Austrian investigators have used PET and MRI to find out that patients with a malignant tumor in one breast have lower levels of certain biomarkers in the contralateral, healthy breast. They examined 141 women who had imaging abnormalities in one breast and a tumor-free contralateral breast.
January 23, 2020
2017 04 26 09 33 44 837 Austrian Flag 400
Previous Page
Page 42 of 121
Next Page